Search Results - "Lage, Maureen"

The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database by Lage, Maureen J., Boye, Kristina S.

“…To examine the relationship between hemoglobin A1c (HbA1c) reduction and healthcare costs among patients with type 2 diabetes (T2D). Truven MarketScan…”
Get full text

1008-P: The Relationship between Glycemic Control and Total Health Care Costs for Adults with Type 2 Diabetes in the U.S by BAE, JAY P., THIEU, VIVIAN, LAGE, MAUREEN J., BOYE, KRISTINA

“…Introduction: The estimated economic costs of diabetes was $327B in 2017 and is forecasted to increase to $494B by 2030. This study compares total health care…”
Get full text

469-P: Direct Medical Costs Associated with Cardiovascular Complications for Adults with Type 2 Diabetes—Evidence from a U.S. Retrospective Study by BAE, JAY P., THIEU, VIVIAN, LAGE, MAUREEN J., BOYE, KRISTINA

“…Introduction: Cardiovascular (CV) disease is a major cause of morbidity and mortality for people with diabetes. This study examines the annual medical costs of…”
Get full text

Comment on generalizability of GLP-1 RA CVOTs in US T2D population by Lage, Maureen J

“…Previous research overstated the generalizability of the Exenatide Study of Cardiovascular Event Lowering trial results by omitting the restriction on the…”
Get full text

Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity by Boye, Kristina S., Lage, Maureen J., Terrell, Kendra

“…Examine the burden of comorbid obesity associated with type 2 diabetes (T2D). The IBM® MarketScan® Explorys Claims Electronic Medical Records Data were used to…”
Get full text

Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data by Boye, Kristina S., Lage, Maureen J., Thieu, Vivian, Shinde, Shraddha, Dhamija, Shivanie, Bae, Jay Patrick

“…To examine body mass index (BMI) and HbA1c for individuals with type 2 diabetes (T2D) in the United States. The retrospective study utilized data from IBM®…”
Get full text

938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes by MALIK, RALEIGH E., MODY, REEMA, LAGE, MAUREEN J., BOYE, KRISTINA

“…Onjective: Examine the relationship between timing of initiation on a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and HbA1c. Methods: The IBM…”
Get full text

The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study by Boye, Kristina S., Thieu, Vivian T., Lage, Maureen J., Miller, Heather, Paczkowski, Rosirene

“…Introduction The prevalence of type 2 diabetes (T2D) represents a rising burden in the US and worldwide, with the condition shown to be associated with…”
Get full text

1161-P: Differences in U.S. Health Care Costs for Patients with Type 2 Diabetes: A Comparison Based upon HbA1c Thresholds by BOYE, KRISTINA, LAGE, MAUREEN J., RAIBULET, NEDINA K., YU, MARIA

“…Objective: The ADA defines normoglycemia as HbA1c < 5.7% and glycemic control for most adults with diabetes as HbA1c < 7%. This research examined U.S…”
Get full text

The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study by Hepp, Zsolt, Lage, Maureen J, Espaillat, Ramon, Gossain, Ved V

“…To examine direct and indirect economic burden associated with hypothyroidism in the United States. Medical costs attributable to hypothyroidism were estimated…”
Get more information

Outcomes of Medicaid Beneficiaries With Schizophrenia Receiving Clozapine Only or Antipsychotic Combinations by Velligan, Dawn I, Carroll, Cathy, Lage, Maureen J, Fairman, Kathleen

“…Objective:Patients with treatment-resistant schizophrenia commonly receive nonrecommended drug regimens, including antipsychotic polypharmacy, sometimes in…”
Get full text

The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes by Boye, Kristina S., Mody, Reema, Lage, Maureen J., Malik, Raleigh E.

“…This study examines the relationship between timing of initiation on a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glycosylated hemoglobin (HbA1c)…”
Get full text

Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database by Lage, Maureen J., Vora, Jamie, Hepp, Zsolt, Espaillat, Ramon

“…Background Approximately 2–4% of women of reproductive age have hypothyroidism. This study characterizes pregnant women with hypothyroidism and examines…”
Get full text

Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018 by Perez-Nieves, Magaly, Juneja, Rattan, Fan, Ludi, Meadows, Eric, Lage, Maureen J, Eby, Elizabeth L

“…Background: The delivery and administration of insulin has undergone many changes over the years. This research examines U.S. trends in insulin use among…”
Get full text

1164-P: The Prevalence of Comorbidities among People with Obesity with and without Prediabetes by FORD, JANET, LAGE, MAUREEN J., BOYE, KRISTINA, BAE, JAY P., TERRELL, KENDRA A., BUNCK, MATHIJS C.

“…Objective: Obesity and prediabetes are widespread in the U.S., with an estimated 42% of adults living with obesity and 35% living with prediabetes. This…”
Get full text

The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US by Hepp, Zsolt, Lage, Maureen J, Espaillat, Ramon, Gossain, Ved V

“…To evaluate outcomes associated with adherence to levothyroxine (LT4) in the US adult hypothyroidism population. We used data from Truven's MarketScan…”
Get more information

Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019 by Boye, Kristina S., Lage, Maureen J., Shinde, Shraddha, Thieu, Vivian, Bae, Jay Patrick

“…Introduction Given the high rates of obesity and poor glycemic control among individuals with type 2 diabetes (T2D), this study examines current trends in…”
Get full text

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States by Boye, Kristina S., Riddle, Matthew C., Gerstein, Hertzel C., Mody, Reema, Garcia‐Perez, Luis‐Emilio, Karanikas, Chrisanthi A., Lage, Maureen J., Riesmeyer, Jeffrey S., Lakshmanan, Mark C.

“…Aim To examine the generalizability of results from glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) cardiovascular outcome trials (CVOTs) in the US type 2…”
Get full text

Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data by Carroll, Cathryn A, Fairman, Kathleen A, Lage, Maureen J

“…For patients with multiple sclerosis (MS), previous research identified key disease sequelae as important cost drivers and suggested that among users of…”
Get full text

1033-P: Trends in U.S. Insulin Use for People with Diabetes: 2009-2017 by PEREZ-NIEVES, MAGALY, JUNEJA, RATTAN, FAN, LUDI, MEADOWS, ERIC, LAGE, MAUREEN J., EBY, ELIZABETH L.

“…Objective: Examine trends of insulin regimens, delivery devices and glucose monitoring among people with type 1 diabetes (T1D) or type 2 diabetes (T2D) in the…”
Get full text